Login to Your Account

Politics render Senate hearing on high drug prices a bit un-HELP-ful

By Mari Serebrov
Regulatory Editor

Tuesday, June 13, 2017

Squandering much of what could have been a good opportunity to better understand the pricing of prescription drugs, the U.S. Senate Health, Education, Labor and Pensions Committee reverted to political bickering over repeal of the Affordable Care Act.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription